(Q53377732)
Statements
A phase II study of the dolastatin 15 analogue LU 103793 in the treatment of advanced non-small-cell lung cancer. (English)
Randolph S Marks
David L Graham
Jeff A Sloan
Shauna Hillman
Steven Fishkoff
James E Krook
Scott H Okuno
James A Mailliard
Tom R Fitch
Ferdinand Addo
1 August 2003
26
4
336-337